Slovenia has started using monoclonal antibody treatment for some patients with Covid-19, having received a shipment of 1,000 doses of a drug as part of an EU contract.
The combination of two antibody treatments, casirivimab and imdevimab, is used at the request of attending physicians under a temporary permit from the Slovenian Agency for Medicinal Products and Medical Devices, the Health Ministry said.
STA
